Search Results - David M. Zahrieh

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study

    Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study by Derlis Gonzalez, Hadhami Ben Turkia, Elena Lukina, Isaac Kisinovsky, Marie‐Françoise Ben Dridi, Deborah Elstein, David M. Zahrieh, Eric Crombez, Kiran Bhirangi, Norman W. Barton, Ari Zimran

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)

    Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216) by Kenneth L. Kehl, David M. Zahrieh, Ping Yang, Shauna L. Hillman, Angelina D. Tan, Jacob Sands, Geoffrey R. Oxnard, Erin A. Gillaspie, Dennis A. Wigle, Shakun Malik, Thomas E. Stinchcombe, Suresh S. Ramalingam, Karen Kelly, Ramaswamy Govindan, Sumithra J. Mandrekar, Raymond U. Osarogiagbon, David Kozono

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase

    Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase by Ari Zimran, Gregory M. Pastores, Anna Tylki‐Szymańska, Derralynn Hughes, Deborah Elstein, Rebecca Mardach, Christine M. Eng, Laurie D. Smith, Margaret A. Heisel‐Kurth, Joel Charrow, Paul Harmatz, Paul M. Fernhoff, William J. Rhead, Nicola Longo, Pilar Giraldo, Juan Ruiz, David M. Zahrieh, Eric Crombez, Gregory A. Grabowski

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

    Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma by Robert E. Schoen, Lisa A. Boardman, Marcia Cruz‐Correa, Ajay Bansal, David Kastenberg, Chin Hur, Lynda Dzubinski, Sharon F. Kaufman, Luz M. Rodriguez, Ellen Richmond, Asad Umar, Éva Szabó, Andres Μ. Salazar, John McKolanis, Pamela Beatty, Reetesh K. Pai, Aatur D. Singhi, Camille M. Jacqueline, Riyue Bao, Brenda Diergaarde, Ryan P. McMurray, Carrie Strand, Nathan R. Foster, David M. Zahrieh, Paul J. Limburg, Olivera J. Finn

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: